Germany is continuing to see cannabis companies from across the globe pile into its medical cannabis market in the hopes of securing their piece of the pie. With limited domestic production capacity and by far the largest medical cannabis patient demographic in Europe, imports to the country have almost doubled every year since the inception of the market in 2017, according to the latest figures from Prohibition Partners European Cannabis Report: 7th Edition. The promise of a potential adult-use market within the next few years has exacerbated the scramble for companies to establish a foothold in the medical market, enabling them to have a headstart when it eventually arrives. Despite this rapid influx of investment and product, German medical cannabis telemedicine operator Nowomed says that supply has now outgrown demand, and product saturation is putting some doctors off prescribing. The German Market The German medical cannabis market is continuing to grow steadily, seeing a 43% increase in sales of cannabis to pharmacies last year. According to data from cannabis-aerzte.de, there are now around 138 strains of medical cannabis available in the country, close to three times the amount available in 2019.
Cannabis Business Executive – Cannabis and Marijuana industry news, 05/12/2022 07:59:00